Resorts World New York City to Open Queens’ First Live Table Games Casino on April 28
Resorts World New York City is preparing to launch what is described as the first live table games offering in
Steve Griffin
April 24, 2026
Resorts World New York City is preparing to launch what is described as the first live table games offering in
The Downtown Breakfast Club has announced the winners of its 44th Annual Roses & Lemon Awards, recognizing a wide range
Montclair-based restaurant Boschetto is set to open its second location at The Park, a 185-acre mixed-use campus in Berkeley Heights,
Hubbard Street Group has secured a lease with Whole Foods Market for a new location in Chicago’s East Lakeview neighborhood.
SVN Chicago Commercial has closed the sale of the Hilton Garden Inn Mattoon, a recently built select-service hotel in Mattoon,
Knighthead Funding has provided a $39.75 million first mortgage to refinance Stadium Crossing, a student housing community serving Indiana University.
The sale of a six-unit multifamily property in Boston’s Brighton neighborhood for $4,595,000 was successfully arranged by Marcus & Millichap.
Cushman & Wakefield has successfully assisted Lincoln Equities Group and PCCP, LLC in obtaining $126,290,000 in refinancing for their newly-constructed
Cushman & Wakefield has successfully assisted Lincoln Equities Group and PCCP, LLC in obtaining a $126,290,000 refinancing for their newly-built
JEMB Realty has recently signed a long-term lease with Rubenstein Law, a Miami-based personal injury firm. The lease is for
Vaxcyte, Inc., a clinical-stage biopharmaceutical company, has signed a 10-year lease with Alexandria Real Estate Equities, Inc. for 258,581 square
Cushman & Wakefield recently advised RPG, a San Diego-based company, in the forward sale of an 88,552-square-foot industrial building located
Coastal Ridge, a company specializing in real estate investment, development and property management for rental properties, has welcomed Peter Kelly
Trammell Crow Company (TCC) has recently secured a lease agreement with COUR Pharmaceuticals, a leading biotechnology company specializing in autoimmune